All About PAH:
Case Study Initial Presentation
Case Study Past Medical History
Case Study Physical Exam
Case Study Test Results
Case Study RHC Results
Algorithm for Treatment-Naive PAH Patient
Risk Assessment in PAH
Monotherapy Therapy Recommendations for WHO FC III PAH
Sequential Combination Therapy Recommendations for WHO FC III PAH
Recommendations for Initial Combination Therapy for WHO FC III
AMBITION Study
An Evolving Paradigm From Sequential to Initial Upfront Combination Therapy
Case Study Patient Initiates PAH Treatment
Case Study Follow-Up 4 Months Later
Case Study Follow-Up Echo
Algorithm for Patient Receiving PAH Treatment
French Registry
French Registry (cont)
French Registry Predictive Value of Individual Variables
French Registry: Survival Based on Number of Low-Risk Criteria Achieved at First Evaluation
COMPERA Registry Risk Stratification
Swedish Registry: Comprehensive Risk Stratification at Early Follow-up Determines Prognosis
Case Study Patient Not at Goal
GRIPHON Study Design
Effect of Selexipag on Primary Composite Endpoint in GRIPHON
GRIPHON Treatment Effect by Subgroup
GRIPHON: Selexipag Titration and Dosing
Case Study Follow-Up and RHC Results
Pilot Study Initial Triple Combination Therapy
Initial Triple Therapy
Concluding Remarks
Abbreviations
Abbreviations (cont)
Abbreviations (cont)
Abbreviations (cont)